Neurogene Inc. ($NGNE)
Filing Information
| Accession Number | 0001543663-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
153,900
Total Value
$0.00
P&L
+inf% (+$2,931,795.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and CFO | Common Stock | โ | Feb 20, 2026 | Grant/Award | 22,000 | $0.00 | $0.00 | 114,643 | Direct | โ | View Details | |
President and CFO | Stock Option (Right to Buy) | Derivative | Feb 20, 2026 | Grant/Award | 131,900 | $0.00 | $0.00 | 131,900 | Direct | โ | View Details |